Clinical Trial Update: A Study of ASP2016 in Adults Who Have Heart Disease Associated With Friedreich Ataxia [Phase 1]

View source ↗

Summary

A Phase 1 trial of ASP2016 in adults with Friedreich Ataxia-associated cardiomyopathy has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiomyopathy
• Friedreich Ataxia

Drugs mentioned

• ASP2016

Snippet

Sponsor: Astellas Gene Therapies | Conditions: Friedreich Ataxia, Cardiomyopathy | Phase 1 | Status: WITHDRAWN